HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹522 Cr | ₹550 Cr | ₹442 Cr | ₹438 Cr | ₹486 Cr |
What is the latest Sundry Debtors ratio of HIKAL ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹522 Cr |
| Mar2024 | ₹550 Cr |
| Mar2023 | ₹442 Cr |
| Mar2022 | ₹438 Cr |
| Mar2021 | ₹486 Cr |
How is Sundry Debtors of HIKAL Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹522 Cr | -5.07 | |
| Mar2024 | ₹550 Cr | 24.56 | |
| Mar2023 | ₹442 Cr | 0.93 | |
| Mar2022 | ₹438 Cr | -9.85 | |
| Mar2021 | ₹486 Cr | - | |
Compare Sundry Debtors of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,340.9 Cr | 4.6% | 21.8% | -52.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,859.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 4.6% |
21.8% |
-52.2% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses